Abrexa Pharmaceuticals

San Diego, United States

Abrexa Pharmaceuticals is a developer of drugs designed to treat Alzheimer disease.

$23.0M raised

Apr 2025

Series B

Health Care Pharmaceutical Service Industry

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Abrexa Pharmaceuticals

How much funding has Abrexa Pharmaceuticals raised?

Abrexa Pharmaceuticals has raised $23.0M in total funding. The most recent round was Series B. The last funding was announced in April 2025.

Where is Abrexa Pharmaceuticals headquartered?

Abrexa Pharmaceuticals is headquartered in San Diego, United States.

What does Abrexa Pharmaceuticals do?

Abrexa Pharmaceuticals is a developer of drugs designed to treat Alzheimer disease.

What stage is Abrexa Pharmaceuticals at?

Abrexa Pharmaceuticals is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2025.

MLA

"Abrexa Pharmaceuticals — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/abrexa-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2025). Abrexa Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/abrexa-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Abrexa Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/abrexa-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2025.